Literature DB >> 11172419

Hirschsprung's disease: a more generalised neuropathy?

W Cheng1, D K Au, C H Knowles, P Anand, P K Tam.   

Abstract

BACKGROUND/
PURPOSE: Aberrant neural crest migration is implicated in the pathogenesis of hindgut aganglionosis in Hirschsprung's disease (HSCR). Neural crest progenitors also give rise to a variety of cell types outside the gut, including nerves of the inner ear and peripheral nervous system. This study aims to determine whether such nerves are also affected in HSCR.
METHODS: Pure tone audiometry and oto-acoustic emission tests were performed on 53 patients with Hirschsprung's disease and 28 age-matched controls. Forty-two children with Hirschsprung's disease and 30 age-matched controls also underwent neurologic evaluation, including quantitative peripheral tests of sensory function.
RESULTS: Moderate to severe sensorineural hearing loss (1 profound [Waardenburg syndrome] and 3 high frequency) was detected in 4 children (8%) from the Hirschsprung's group. Abnormal (absent or reduced) oto-acoustic emission was detected in 77 of 102 ears (41 of 51 patients) in the HSCR group and 8 out of 48 ears (6 of 24 children) in the control group (75% v 17%; P<.0001). Two HSCR children had marked abnormalities on tests of peripheral nerve function. Significantly higher thresholds for vibration sensation were detected in HSCR versus controls (P<.05).
CONCLUSION: Hirschsprung's disease may have a more generalised neuropathy than just that involving the affected bowel.

Entities:  

Mesh:

Year:  2001        PMID: 11172419     DOI: 10.1053/jpsu.2001.20695

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Sox10 regulates ciliary neurotrophic factor gene expression in Schwann cells.

Authors:  Yasuhiro Ito; Stefan Wiese; Natalja Funk; Alexandra Chittka; Wilfried Rossoll; Heike Bömmel; Kazuhiko Watabe; Michael Wegner; Michael Sendtner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.